1. Home
  2. SKYW vs CRNX Comparison

SKYW vs CRNX Comparison

Compare SKYW & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWest Inc.

SKYW

SkyWest Inc.

HOLD

Current Price

$83.69

Market Cap

3.6B

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$38.96

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYW
CRNX
Founded
1972
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.9B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
SKYW
CRNX
Price
$83.69
$38.96
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$123.67
$76.75
AVG Volume (30 Days)
349.6K
971.8K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
33.20
N/A
EPS
2.50
N/A
Revenue
$2,971,963,000.00
$1,039,000.00
Revenue This Year
$8.35
$720.10
Revenue Next Year
$3.55
$184.67
P/E Ratio
$33.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$80.00
$25.83
52 Week High
$123.94
$57.99

Technical Indicators

Market Signals
Indicator
SKYW
CRNX
Relative Strength Index (RSI) 37.51 51.30
Support Level N/A $33.19
Resistance Level $102.83 $45.32
Average True Range (ATR) 3.30 1.47
MACD -1.28 0.00
Stochastic Oscillator 16.51 40.75

Price Performance

Historical Comparison
SKYW
CRNX

About SKYW SkyWest Inc.

SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. SkyWest generally provides regional flights and utilizes smaller, lower-cost aircraft to carry passengers who book tickets through partner airlines. It partners with carriers to fly and operate aircraft for a fee and may use the carriers' brands and ground support to coordinate marketing and transport passengers. The company has two reportable segments: SkyWest Airlines and SWC, which generate maximum revenue, and SkyWest Leasing activities.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Share on Social Networks: